Riskpilot← Back to searchSign inGet full accessEr klinik Sverige AB
ABBankruptOrg 5591409064Medical specialists activities · NACE 8622Est. 20170 employees
Revenue 2021
SEK 1,4M
EBITDA margin
-269.8%
-960% vs 2020
Equity ratio
97.4%
Financial strength
Net profit 2021
SEK -4,6M
-1220% vs 2020
| Revenue | SEK 1,4M | — |
| EBITDA | SEK -3,7M | -960% |
| Net profit | SEK -4,6M | -1220% |
| Total assets | SEK 16,9M | +11% |
| Equity | SEK 16,5M | +10% |
| Employees | 0 | — |
Legal name
Er klinik Sverige AB
Org number
5591409064
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
19 december 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva medicinska specialistläkartjänster, kirurgiska ingrepp, skönhetsvård och hudvård inkluderande laserbehandling, medicinsk konsultverksamhet, försäljning av medicinska artiklar och hudvårdsprodukter. Bolaget skall även bedriva konsultation och undervisning inom hälso- och sjukvård samt skönhetsvård, förvalta och äga värdepapper, bedriva personaluthyrning, handla med och förvaltning av fastigheter, investera i aktier samt därmed förenlig verksamhet.
Address
Email
jimmy@sadvokat.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | — | 0 | 0 | 1 360 |
| Staff expenses | — | — | — | — |
| EBITDA | 0 | −272 | −346 | −3 669 |
| Depreciation & amort. | — | −0 | −0 | −908 |
| EBIT | 0 | −272 | −346 | −4 577 |
| Net financials | — | — | −1 | −3 |
| Profit before tax | 0 | −272 | −347 | −4 580 |
| Tax | — | −0 | −0 | −0 |
| Net profit | — | −272 | −347 | −4 580 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | — | 12 296 | 15 218 | 16 894 |
| Equity | — | 12 296 | 14 955 | 16 453 |
| Long-term debt | — | 0 | 0 | 0 |
| Short-term debt | — | 0 | 264 | 441 |
| Total debt | — | — | 264 | 441 |
EBITDA margin
-269.8%
This company
15.8%
Market median
-1808% vs market
20182021
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
20182021
Return on equity
-27.8%
This company
18.4%
Market median
-251% vs market
20182021
Net profit margin
-336.8%
This company
8.1%
Market median
-4258% vs market
20182021
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20182021
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20182021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-12-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JK Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2023 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 54% | 54% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
M.A.J Invest AB
Er klinik Sverige AB Board members of Er klinik Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Kent William Schiöld | Liquidator | 0 companies |
| Vilyam Vilyan Melki | Chairman | 0 companies |
| Kenan Anter | Board of Directors | 0 companies |